Housatonic Valley Health District is committed to providing weekly in-depth COVID-19 reports, which are published every Friday.
Update from Lisa Morrissey, Director of Health
COVID-19 Mask Wearing Updates:
On February 18, 2022, Connecticut Department of Public Health and Connecticut State Department of Education Release Updated School Guidance, which was accompanied by two documents.
Click here to read the “Considerations for Boards of Education, District Administrators, and other Local Decision-Makers Regarding Potential Changes to School COVID-19 Policies and Practices” document.
Click here to read the “Transitioning to a Model of Routine Respiratory Disease Prevention and Enhanced Outbreak Management and Control for COVID-19 in PreK-12 School Settings” document
Connecticut Office of Early Childhood (OEC) has not released updated guidance for daycares.
COVID-19 Vaccination Updates:
|Primary Series Vaccine Manufacturer||Age Group||Number of doses in primary series||Interval between 1st & 2nd dose||Number of Booster Doses||Interval between primary series and booster dose|
|Pfizer-BioNTech||5-11 years||2||3 weeks||N/A||N/A|
|Pfizer-BioNTech||12+ years||2||3-8 weeks*||1||> 5 months|
|Moderna||18+ years||2||4-8 weeks*||1||> 5 months|
|Janssen||18+ years||1||N/A||1||> 2 months|
*An 8-week interval may be optimal for people ages 12 to 64 years, especially for males ages 12 to 39, who are not moderately or severely immunocompromised. A shorter interval between the first and second dose remains recommended for people who are moderately or severely immunocompromised, adults 65 years and older, and others who need early protection due to increased concern about community transmission or risk of severe disease (CDC).